How Myers was paid
$1.4M in total for fiscal 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Dr. Michael MyersChief Executive Officer | $662,475 | $331,238 | $353,013 | $60,075 | $1,406,801 |
| Denise CarterChief Operating Officer | $529,980 | $264,640 | $353,017 | $63,625 | $1,211,262 |
| Gordon DunnChief Financial Officer | $433,620 | — | $223,012 | — | $656,632 |
What changed and why
- $1.4M$1,406,801 CEO total compensation increased from $1,255,188 in 2023.
- $662K$662,475 CEO salary and $331,238 bonus reflected compensation approved or ratified for 2024.
- $353K$353,013 CEO option award was granted December 9, 2024, with a $27.30 exercise price.
- 50%50% of annual base salary is the shareholder-approved maximum cash bonus for the CEO and COO.
- 500%500% of fixed compensation is the annual equity grant value limit for the CEO and COO.
- $223K$223,012 CFO option award accompanied $433,620 salary; no 2024 bonus or other compensation was reported.
Other Quoin Pharmaceuticals proxy statements
- 2026 proxy statement
Dr. Michael Myers paid $1.5M (+7% on the year).
Filed Jul 16, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.